IGEA Pharma NV
SIX:IGPH

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
SIX:IGPH
Watchlist
Price: 0.0005 CHF Market Closed
Market Cap: 505.5k CHF

Operating Margin
IGEA Pharma NV

0%
Current
-1 743%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-335.6k
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

IGEA Pharma NV
Glance View

Market Cap
505.5k CHF
Industry
Health Care

IGEA Pharma NV is a health-tech company focused on measure and control of test factors related to life-threatening diseases. The company is headquartered in Hoofddorp, Noord-Holland. The company went IPO on 2018-12-20. The firm focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The firm develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer’s disease. The firm offers its services in the Netherlands.

IGPH Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-335.6k
/
Revenue
0
What is the Operating Margin of IGEA Pharma NV?

Based on IGEA Pharma NV's most recent financial statements, the company has Operating Margin of 0%.

Back to Top